This study represents the first demonstration of a glucose‐responsive glucagon‐releasing microneedle patch for hypoglycemia prevention, highlighting its potential to reduce the risks associated with intensive insulin therapy and improve the quality of life for diabetic patients and their caregivers. Here, INS is linked to Hypoglycemia.